Gout’s Alarming Rise
Gout’s alarming rise is hard to ignore, especially when you consider that global cases skyrocketed from about 22.4 million in 1990 to a staggering 55.8 million by 2020. That’s a jaw-dropping increase of 150.6%. If you thought gout was just an old man’s disease, think again.
The age-standardized prevalence rate hit 659.3 per 100,000 in 2020. And guess what? It’s projected to reach a whopping 95.8 million cases by 2050. Buckle up; that’s a 72.6% jump from 2020.
The age-standardized prevalence rate soared to 659.3 per 100,000 in 2020, projected to hit 95.8 million cases by 2050!
Now, let’s talk about the demographics. Men are getting the short end of the stick here—gout strikes them 3.26 times more than women. The numbers don’t lie: 1030.8 per 100,000 men versus a measly 316.4 for women.
And while gout is no picnic for anyone, it contributed to 1.73 million years lived with disability in 2020. Ouch.
Geographically, North America is the heavyweight champion of gout, boasting a prevalence of 1719.8 per 100,000. Other regions, like Australasia and southern Latin America, aren’t far behind.
The United States alone saw a rise from 2.9% to 3.9% of adults with gout between 1988 and 2008. The UK? About 2.5%.
So why the surge? High body mass index is a major culprit, accounting for 34.3% of gout-related disability. Aging populations are also fueling this fire. As people age, gout tends to rear its ugly head. Additionally, the Chronic Refractory Gout market is anticipated to grow due to the launch of emerging therapies between 2024 and 2034.
Add in kidney dysfunction and you’ve got a recipe for disaster.
Let’s not forget about cultural quirks. Some populations, like Taiwanese aboriginal and Māori, report gout rates exceeding 10%.
Meanwhile, in places like rural Turkey and many African countries, it’s practically a ghost. It’s clear: gout isn’t just a personal struggle; it’s a global issue, and it’s getting worse.
